Sterling Capital Management’s Editas Medicine EDIT Stock Holding History

Sterling Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69K	Sell	522 -2,739	-84%	-$8.01K	﹤0.01%	3033
2026 Q1	$8.05K	Sell	3,261 -1,964	-38%	-$4.16K	﹤0.01%	2491
2025 Q4	$10.7K	Sell	5,225 -598	-10%	-$1.73K	﹤0.01%	2572
2025 Q3	$20.2K	Buy	5,823 +3,482	+149%	+$9.72K	﹤0.01%	2135
2025 Q2	$5.15K	Buy	2,341 +852	+57%	+$1.39K	﹤0.01%	2501
2025 Q1	$1.73K	Sell	1,489 -1,326	-47%	-$1.95K	﹤0.01%	2646
2024 Q4	$3.58K	Buy	2,815 +2,502	+799%	+$6.38K	﹤0.01%	2592
2024 Q3	$1.07K	Buy	+313	New	+$1.36K	﹤0.01%	2486
2017 Q2	–	Sell	-9,000	Closed	-$201K	–	949
2017 Q1	$201K	Buy	+9,000	New	+$187K	﹤0.01%	921

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sterling Capital Management's EDIT Position: Q2 2026 in Review

Sterling Capital Management reduced its Editas Medicine (EDIT) stake by 84% in Q2 2026, selling an estimated $8.01K and leaving 522 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.

Sterling Capital Management first reported a position in EDIT in Q1 2017 and has held it in 9 quarters since. The position peaked at $201K in Q1 2017. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Sterling Capital Management held 522 shares of Editas Medicine worth $1.69K as of Q2 2026.
Sterling Capital Management sold 2,739 Editas Medicine shares in Q2 2026, an estimated $8.01K.
Editas Medicine made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3033 holding.
Sterling Capital Management first reported a position in Editas Medicine in Q1 2017 and has held it in 9 quarters since.
Sterling Capital Management's Editas Medicine position peaked at $201K in Q1 2017.
214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.